Aristopharma has launched Livcare 5 & 10 mg Tablet for the treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) including Non-Alcoholic Steatohepatitis (NASH) and Primary Biliary Cholangitis (PBC)

Aristopharma has launched Livcare 5 & 10 mg Tablet for the treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) including Non-Alcoholic Steatohepatitis (NASH) and Primary Biliary Cholangitis (PBC)